Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer’s Mylotarg receives FDA approval for acute myeloid leukaemia treatment

pharmaceufical-technologySeptember 05, 2017

Tag: FDA , Pfizer’s Mylotarg , myeloid leukaemia treatment

PharmaSources Customer Service